FDA panel blesses GSK, Theravance COPD drug
September 10, 2013 at 17:53 PM EDT
Theravance Inc. and partner GlaxoSmithKline plc won an important victory Tuesday as a Food and Drug Administration advisory panel said the companies' experimental once-a-day drug for COPD patients recommended that the treatment be approved...